Dave Chesla is a board certified pathologists assistant by training with focuses in oncology, molecular diagnostics and genomics. His current research interests are Precision Medicine, Proteomics, Perinatal Epidemiology and Theranostics.
Current projects include:
The NIH All of Us Research Program, formerly known as the Precision Medicine Initiative.
The goal of this research is to create a deeper understanding of individualism by creating the largest US research cohort ever, 1 million people. By understanding people's health, neighborhood, family, and lifestyle, researchers may be able to develop new medical treatments that are unique to each person.
The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) is a national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, or proteogenomics.
The Spectrum Health Accelerator of Research Excellence and Biorepository.
He is the Director of Research Operations at Spectrum Health, Grand Rapids, Michigan and a adjunct assistant professor in the department of obstetrics, gynecology and reproductive biology, College of Human Medicine, Michigan State University.